{
    "study_accession": "SDY667",
    "actual_completion_date": null,
    "actual_enrollment": 50,
    "actual_start_date": "2010-11-01",
    "age_unit": "Years",
    "brief_description": "This study will compare adult patients with CPP(chronic plaque type psoriasis ), who are currently not undergoing topical, systemic or biologic treatment and matched healthy controls. Baseline demographics and psoriasis history will be recorded. All PPP patients will be comprehensively phenotyped and psoriasis severity assessed including the body surface area (BSA) involved, Psoriasis Area and Severity Index (PASI), Physicians Global assessment (PGA) and Dermatology Life Quality Index (DLQI).",
    "brief_title": "The immune signature of palmoplantar pustulosis",
    "clinical_trial": "N",
    "condition_studied": "Patients with PPP compared to healthy controls (recruited also at the derm clinic).In addition, archived samples from healthy donors and patients with chronic plaque type psoriasis (CPP) will be included",
    "dcl_id": 2,
    "description": "This study will compare adult patients with CPP(chronic plaque type psoriasis ), who are currently not undergoing topical, systemic or biologic treatment and matched healthy controls. Baseline demographics and psoriasis history will be recorded. All PPP patients will be comprehensively phenotyped and psoriasis severity assessed including the body surface area (BSA) involved, Psoriasis Area and Severity Index (PASI), Physicians Global assessment (PGA) and Dermatology Life Quality Index (DLQI).",
    "doi": "10.21430/M34NBAVDGJ",
    "endpoints": "This study will compare adult patients with CPP, who are currently not undergoing topical, systemic or biologic treatment and matched healthy controls",
    "gender_included": "Female, Male",
    "hypothesis": "PPP immune signatures differ from that of healthy individuals and from other more frequent forms of psoriasis",
    "initial_data_release_date": "2016-03-18",
    "initial_data_release_version": "DR18",
    "intervention_agent": null,
    "latest_data_release_date": "2018-07-06",
    "latest_data_release_version": "DR27",
    "maximum_age": "  68.00",
    "minimum_age": "  24.00",
    "objectives": "To identify transcriptional signatures in the blood of patients with palmoplantar pustulosis (PPP) and their modulation through in vivo stimulation with vaccination.",
    "official_title": "The immune signature of palmoplantar pustulosis",
    "sponsoring_organization": "NIAID",
    "target_enrollment": null,
    "workspace_id": 2799,
    "research_focus": [
        "Vaccine Response"
    ],
    "arm": [
        {
            "arm_accession": "ARM2929",
            "description": "Subjects are age 18 years or older, with a diagnosis of palmoplantar pustulosis (PPP)",
            "name": "HIPC-PSOR-PPP"
        }
    ],
    "personnel": [
        {
            "first_name": "Gerlinde",
            "last_name": "Obermoser",
            "organization": "Baylor Institute for Immunology research",
            "role_in_study": "Principal Investigator",
            "site_name": "Baylor Institute for Immunology research"
        }
    ],
    "pubmed": [],
    "program": [
        {
            "program_name": "Human Immunology Project Consortium (HIPC) RFA-AI-14-007",
            "contract_name": "Systems Analysis Vaccine Responses in Healthy and Hyporesponsive Humans"
        }
    ],
    "assay": [
        {
            "measurement_technique": "Transcription profiling by array",
            "number_of_expsamples": 138
        }
    ],
    "subject": {
        "race": [
            {
                "race": "Asian",
                "count": 4
            },
            {
                "race": "Black or African American",
                "count": 3
            },
            {
                "race": "White",
                "count": 43
            }
        ],
        "gender": [
            {
                "Female": 28
            },
            {
                "Male": 22
            }
        ]
    }
}
